RTOG Foundation, Inc.
Bevacizumab With or Without Radiation Therapy in Treating Patients With Recurrent Glioblastoma
- Conditions
- Interventions
- First Posted Date
- 2012-11-21
- Last Posted Date
- 2022-12-29
- Lead Sponsor
- Radiation Therapy Oncology Group
- Target Recruit Count
- 182
- Registration Number
- NCT01730950
- Locations
- 🇺🇸
University of Miami Miller School of Medicine-Sylvester Cancer Center, Miami, Florida, United States
🇺🇸Bay Area Medical Center, Marinette, Wisconsin, United States
🇺🇸Yale University, New Haven, Connecticut, United States
Sorafenib Tosylate With or Without Stereotactic Body Radiation Therapy in Treating Patients With Liver Cancer
- Conditions
- Interventions
- First Posted Date
- 2012-11-21
- Last Posted Date
- 2024-10-10
- Lead Sponsor
- Radiation Therapy Oncology Group
- Target Recruit Count
- 193
- Registration Number
- NCT01730937
- Locations
- 🇺🇸
University of Pennsylvania/Abramson Cancer Center, Philadelphia, Pennsylvania, United States
🇺🇸Washington University School of Medicine, Saint Louis, Missouri, United States
🇺🇸Penn State Milton S Hershey Medical Center, Hershey, Pennsylvania, United States
TRYHARD: Radiation Therapy Plus Cisplatin With or Without Lapatinib in Treating Patients With Head and Neck Cancer.
- Conditions
- Interventions
- First Posted Date
- 2012-10-22
- Last Posted Date
- 2023-10-17
- Lead Sponsor
- Radiation Therapy Oncology Group
- Target Recruit Count
- 142
- Registration Number
- NCT01711658
- Locations
- 🇺🇸
University of California, San Diego, La Jolla, California, United States
🇺🇸Sutter General Hospital, Sacramento, California, United States
🇨🇦McGill Cancer Centre at McGill University, Montreal, Quebec, Canada
Standard Versus Intensity-Modulated Pelvic Radiation Therapy in Treating Patients With Endometrial or Cervical Cancer
- First Posted Date
- 2012-08-27
- Last Posted Date
- 2022-06-15
- Lead Sponsor
- Radiation Therapy Oncology Group
- Target Recruit Count
- 289
- Registration Number
- NCT01672892
- Locations
- 🇺🇸
Longmont United Hospital, Longmont, Colorado, United States
🇺🇸Greater Baltimore Medical Center, Baltimore, Maryland, United States
🇺🇸The Mark H Zangmeister Center, Columbus, Ohio, United States
Hormone Therapy, Radiation Therapy, and Steroid 17alpha-monooxygenase TAK-700 in Treating Patients With High-Risk Prostate Cancer
- Conditions
- Interventions
- First Posted Date
- 2012-03-07
- Last Posted Date
- 2023-04-18
- Lead Sponsor
- Radiation Therapy Oncology Group
- Target Recruit Count
- 239
- Registration Number
- NCT01546987
- Locations
- 🇺🇸
Ohio State University Medical Center, Columbus, Ohio, United States
🇺🇸Case Western Reserve University, Cleveland, Ohio, United States
🇺🇸Saint John's Mercy Medical Center, Saint Louis, Missouri, United States
Radiation Therapy in Treating Patients With Prostate Cancer
- Conditions
- Interventions
- First Posted Date
- 2011-09-14
- Last Posted Date
- 2022-06-09
- Lead Sponsor
- Radiation Therapy Oncology Group
- Target Recruit Count
- 255
- Registration Number
- NCT01434290
- Locations
- 🇨🇦
London Regional Cancer Program at London Health Sciences Centre, London, Ontario, Canada
🇺🇸Emory Crawford Long Hospital, Atlanta, Georgia, United States
🇺🇸Winship Cancer Institute of Emory University, Atlanta, Georgia, United States
Natural History of Brain Function, Quality of Life, and Seizure Control in Patients With Brain Tumor Who Have Undergone Surgery
- Conditions
- Interventions
- First Posted Date
- 2011-08-16
- Last Posted Date
- 2015-03-18
- Lead Sponsor
- Radiation Therapy Oncology Group
- Target Recruit Count
- 82
- Registration Number
- NCT01417507
- Locations
- 🇺🇸
Waukesha Memorial Hospital, Waukesha, Wisconsin, United States
🇺🇸Piedmont Hospital, Atlanta, Georgia, United States
🇺🇸Radiation Therapy Oncology Group, Philadelphia, Pennsylvania, United States
Rituximab, Methotrexate, Vincristine Sulfate, Procarbazine Hydrochloride, and Cytarabine With or Without Radiation Therapy in Treating Patients With Primary Central Nervous System Lymphoma
- First Posted Date
- 2011-07-21
- Last Posted Date
- 2023-07-20
- Lead Sponsor
- Radiation Therapy Oncology Group
- Target Recruit Count
- 91
- Registration Number
- NCT01399372
- Locations
- 🇺🇸
Fresno Cancer Center, Fresno, California, United States
🇺🇸Northwestern University, Chicago, Illinois, United States
🇺🇸Rush University Medical Center, Chicago, Illinois, United States
Androgen-Deprivation Therapy and Radiation Therapy in Treating Patients With Prostate Cancer
- Conditions
- Interventions
- First Posted Date
- 2011-06-08
- Last Posted Date
- 2023-08-16
- Lead Sponsor
- Radiation Therapy Oncology Group
- Target Recruit Count
- 2592
- Registration Number
- NCT01368588
- Locations
- 🇺🇸
Los Angeles County-USC Medical Center, Los Angeles, California, United States
🇺🇸Emory University Hospital Midtown, Atlanta, Georgia, United States
🇺🇸Rush University Medical Center, Chicago, Illinois, United States
Higher Per Daily Treatment-Dose Radiation Therapy or Standard Per Daily Treatment Radiation Therapy in Treating Patients With Early-Stage Breast Cancer That Was Removed by Surgery
- Conditions
- Interventions
- First Posted Date
- 2011-05-06
- Last Posted Date
- 2023-04-06
- Lead Sponsor
- Radiation Therapy Oncology Group
- Target Recruit Count
- 2354
- Registration Number
- NCT01349322
- Locations
- 🇺🇸
University of Maryland/Greenebaum Cancer Center, Baltimore, Maryland, United States
🇺🇸Texas Oncology - Denison Cancer Center, Denison, Texas, United States
🇺🇸Northside Hospital, Atlanta, Georgia, United States